A growing number of financially needy people in India are over-volunteering for bioequivalence clinical trials to supplement their income, putting at risk the health of these “serial volunteers” and the reliability of trial data. France and the United Kingdom have a national registry of study volunteers to prevent serial volunteering and deception to qualify for trials, but India and the U.S. do not. (THE HINDU)